Sg Americas Securities, LLC Beam Therapeutics Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 10,147 shares of BEAM stock, worth $294,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,147

Previous 19,142 46.99%

Holding current value

$294,364

Previous $448,000 44.42%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$22.57 - $33.14 $203,017 - $298,094	-8,995 Reduced 46.99%	10,147 $249,000
Q2 2024 Jul 12, 2024	BUY	$21.22 - $32.66 $276,241 - $425,167	13,018 Added 212.57%	19,142 $448,000
Q1 2024 May 06, 2024	SELL	$23.46 - $45.07 $204,571 - $393,010	-8,720 Reduced 58.74%	6,124 $202,000
Q4 2023 Jan 12, 2024	SELL	$17.69 - $30.76 $4,493 - $7,813	-254 Reduced 1.68%	14,844 $404,000
Q3 2023 Oct 13, 2023	BUY	$23.01 - $32.46 $347,404 - $490,081	15,098 New	15,098 $363,000
Q1 2023 Apr 28, 2023	BUY	$30.15 - $48.79 $364,513 - $589,871	12,090 Added 288.75%	16,277 $498,000
Q4 2022 Feb 02, 2023	SELL	$36.73 - $51.6 $131,419 - $184,624	-3,578 Reduced 46.08%	4,187 $164,000
Q3 2022 Oct 31, 2022	SELL	$39.79 - $70.31 $812,432 - $1.44 Million	-20,418 Reduced 72.45%	7,765 $370,000
Q2 2022 Jul 29, 2022	BUY	$29.86 - $62.36 $673,820 - $1.41 Million	22,566 Added 401.74%	28,183 $1.09 Million
Q1 2022 Apr 29, 2022	SELL	$53.73 - $82.16 $482,764 - $738,207	-8,985 Reduced 61.53%	5,617 $322,000
Q4 2021 Feb 07, 2022	SELL	$68.02 - $99.06 $412,541 - $600,798	-6,065 Reduced 29.35%	14,602 $1.16 Million
Q3 2021 Nov 01, 2021	BUY	$84.37 - $133.6 $712,082 - $1.13 Million	8,440 Added 69.03%	20,667 $1.8 Million
Q2 2021 Aug 12, 2021	BUY	$64.12 - $128.71 $82,137 - $164,877	1,281 Added 11.7%	12,227 $1.57 Million
Q1 2021 May 13, 2021	BUY	$71.28 - $120.75 $780,230 - $1.32 Million	10,946 New	10,946 $876,000
Q3 2020 Nov 09, 2020	SELL	$19.0 - $30.57 $130,454 - $209,893	-6,866 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$15.26 - $28.66 $104,775 - $196,779	6,866 New	6,866 $192,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Beam Therapeutics Inc. Transaction History